Free Trial

LENZ Therapeutics (LENZ) SEC Filings & 10K Form

LENZ Therapeutics logo
$27.06 +0.11 (+0.40%)
As of 10:31 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent LENZ Therapeutics SEC Filings

DateFilerForm TypeView
04/15/2025
7:37 AM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2025
11:15 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form EFFECT
04/14/2025
11:15 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form EFFECT
04/09/2025
6:20 PM
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:05 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
04/09/2025
3:06 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
04/08/2025
11:15 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form EFFECT
04/08/2025
11:15 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form EFFECT
04/04/2025
3:45 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form POS AM
04/04/2025
3:46 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form POS AM
04/04/2025
3:48 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/04/2025
3:53 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/19/2025
3:45 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/19/2025
3:38 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
5:10 PM
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:26 PM
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:20 PM
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:22 PM
Chevallard Daniel R. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:24 PM
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Odrich Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
6:55 PM
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
4:08 PM
LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SC 13D/A
11/06/2024
7:03 AM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
11/06/2024
7:06 AM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
11/06/2024
6:35 AM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:26 AM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
7:23 AM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
10/28/2024
7:24 AM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
10/28/2024
7:09 AM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
11:15 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form EFFECT
09/19/2024
4:04 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
09/11/2024
3:09 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/14/2024
3:25 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
08/12/2024
7:05 AM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:11 AM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
07/29/2024
3:12 PM
LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Ridgeback Capital Investments L.P. (Filed by)
Form SC 13G
07/23/2024
7:16 PM
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
7:32 AM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
07/15/2024
7:22 AM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
7:31 AM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/14/2024
4:29 PM
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
MCCOLLUM JAMES W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:18 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 424B3
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.
05/08/2024
4:11 PM
LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LENZ) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners